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ABSTRACT
West Nile virus (WNV) is the most important cause of epidemic encephalitis in North America. Innate immune responses, which
are critical for control ofWNV infection, are initiated by signaling through pathogen recognition receptors, RIG-I andMDA5,
and their downstream adaptor molecule, MAVS. Here, we show that a deficiency of MAVS in hematopoietic cells resulted in in-
creased mortality and delayedWNV clearance from the brain. InMavs/mice, a dysregulated immune response was detected,
characterized by a massive influx of macrophages and virus-specific T cells into the infected brain. These T cells were polyfunc-
tional and lysed peptide-pulsed target cells in vitro. However, virus-specific T cells in the brains of infectedMavs/mice exhib-
ited lower functional avidity than those in wild-type animals, and even virus-specific memory T cells generated by prior immuni-
zation could not protectMavs/mice fromWNV-induced lethal disease. Concomitant with ineffective virus clearance,
macrophage numbers were increased in theMavs/ brain, and both macrophages andmicroglia exhibited an activated pheno-
type. Microarray analyses of leukocytes in the infectedMavs/ brain showed a preferential expression of genes associated with
activation and inflammation. Together, these results demonstrate a critical role for MAVS in hematopoietic cells in augmenting
the kinetics ofWNV clearance and thereby preventing a dysregulated and pathogenic immune response.
IMPORTANCE
West Nile virus (WNV) is the most important cause of mosquito-transmitted encephalitis in the United States. The innate im-
mune response is known to be critical for protection in infected mice. Here, we show that expression of MAVS, a key adaptor
molecule in the RIG-I-like receptor RNA-sensing pathway, in hematopoietic cells is critical for protection from lethalWNV in-
fection. In the absence of MAVS, there is a massive infiltration of myeloid cells and virus-specific T cells into the brain and over-
exuberant production of proinflammatory cytokines. These results demonstrate the important role that MAVS expression in
hematopoietic cells has in regulating the inflammatory response in theWNV-infected brain.
West Nile virus (WNV), amosquito-borne, neurotropic flavi-virus, is the most important cause of encephalitis in the
United States, with 20,179 cases of neuroinvasive disease reported
to the CDC since 1999; 1,360 of these cases occurred in 2015.
WNV is an enveloped, positive-strand flavivirus and is related to
Zika virus, which is implicated in Guillain-Barre syndrome and
neonatal microcephaly (1, 2). Humans are a dead-end host for
WNV, with the virus maintained in nature by cycling between
birds and several species of mosquito; Culex mosquitoes are the
most important in this process (2).
C57BL/6 wild-type (WT) mice infected with WNV develop
clinical disease that parallels the disease observed in human pa-
tients, ranging from subclinical infection to encephalitis. While it
is not clear why a specific individual develops severe versus mild
disease, the role for type I interferon (IFN-I) in protection is well
established. Mice deficient in IFN-I receptor (IFNAR), IRF3,
IRF5, IRF7, RIG-I, MDA5, MyD88, or MAVS (also called IPS-1,
STI, VISA, and CARDIF) expression all develop severe disease
(3–6). RIG-I and MDA5 are members of the RIG-I-like receptor
(RLR) family of cytosolic RNA helicases. RLRs function as patho-
gen recognition receptors for RNA viruses, includingWNV. Dur-
ing WNV infection, RIG-I and MDA5 recognize and bind to
pathogen-associated molecular pattern RNA motifs to undergo
signaling activation. The active RLRs then interact with MAVS to
direct downstream induction of gene expression. Mavs/ mice
are especially sensitive to WNV, developing a uniformly lethal
encephalitis (3). In vitro infection of bone marrow-derived mac-
rophages and dendritic cells or neurons revealed increased virus
titers and decreased type I IFN production in cells lacking MAVS
expression (3).
The precise role of MAVS in WNV-infected brains is not well
understood. For example, it is not knownwhetherMAVS expression
in infiltrating hematopoietic or resident brain cells ismost important
for protection (3). Furthermore, the WNV-specific T cell response,
required forvirusclearance, isquantitatively robust inMavs/mice,
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but it is not known whether T cells in these mice are functionality
equivalent to those present in WT mice (3). Here, we show that
MAVS expression inhematopoietic cells ismost important forWNV
clearance in infectedmice. Virus-specific CD8 T cells are detected in
elevatednumbers in thebrains of infectedMavs/ compared toWT
mice but exhibit lower functional avidity thanWT counterparts. Ac-
tivatedT cells andmacrophages accumulate in the brains ofMavs/
mice, resulting in severe inflammation, which contributes to patho-
genesis and a lethal infection.
MATERIALS AND METHODS
Mice, virus, and cells. Mavs/ mice on a C57BL/6 background were
initially obtained as a generous gift from S. Akira (Osaka University,
Osaka, Japan) and modified as described previously (3, 7, 8). C57BL/6
mice were purchased from Charles River Laboratories. C57BL/6-
SJL(CD45.1) mice and Foxp3-IRES-GFP mice were purchased from
Jackson Laboratories. Mavs//Foxp3-IRES-GFP mice and Mavs/
SJL(CD45.1) mice were generated by intercrossing at the University of
Iowa. All the mice were maintained in the specific-pathogen-free Animal
Care Facility at the University of Iowa. All protocols were approved by the
University of Iowa Institutional Animal Care and Use Committee. WNV
strain TX 2002-HC (WNV-TX) was propagated as previously described
(3). Working stocks of WNV-TX were generated by a single round of
amplification on Vero cells. The titers of virus stocks were determined by
a standard plaque assay on Vero cells, as previously described (9). Vero
cells were maintained in Dulbecco’s modified Eagle medium (DMEM)
supplemented with 10% fetal bovine serum (FBS).
FIG 1 MAVS expression in CD45 hematopoietic cells is critical for protection from WNV. (A and B) Eight- to 12-week-old WT and Mavs/ mice were
infectedwith 100PFUWNVin the footpad (subcutaneously [s.c.]). (A) Survival after infection (WT,n 10;Mavs/,n 7;P 0.0002). (B)Numbers ofCD45 cells
in brains at the indicated times p.i. (C, D, and E) Bonemarrow chimeras were generated as described inMaterials andMethods. The chimeric mice were infected with
100 PFUWNV s.c. (C) Survival was monitored daily (Mavs/¡Mavs/, n 4;Mavs/¡WT, n 5;WT¡WT, n 7;WT¡WT, n 7;WT¡Mavs/,
n7;P0.0018[WT¡WTgroupcompared toMavs/¡WTgroup]andP0.0015[WT¡Mavs/groupcompared toMavs/¡Mavs/]).Arrowsdenote
indicated donor bonemarrow transferred into indicated irradiated host. (D) Numbers of CD45 cells from brains at the indicated times p.i. (E) To obtain virus titers,
brains and spleens were homogenized at the indicated time points, and the titers were determined on Vero cells. Titers are expressed as PFU/g tissue. n  5 or 6
mice/group/time point. *, P 0.05. The data were pooled from the results of two independent experiments. The error bars indicate SEM.
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Mouse infections. Age-matched 8- to 12-week-old mice were inocu-
lated subcutaneously (s.c.) in the left rear footpad with 100 PFU of
WN-TX in 20 l of phosphate-buffered saline (PBS) supplemented with
1% heat-inactivated FBS. The mice were monitored daily for morbidity
and mortality.
Mouse bone marrow chimeras. Bone marrow cells were extracted
from femurs and tibia of CD45.1 or CD45.2 congenic WT and Mavs/
mice (all 6 weeks old). Red blood cells (RBCs) were lysed using ACK
(ammonium-chloride-potassium) buffer. Isolated bone marrow cells
(2  107 cells) were transferred adoptively into lethally irradiated (950
rads) CD45.1 or CD45.2mismatched congenicWT andMavs/mice. The
chimericmiceweremaintained onwater supplementedwith antibiotics for 2
weeks to prevent opportunistic infections. Reconstitution was verified 5
weeks after bone marrow transfer by flow cytometry analysis of CD45.1/
CD45.2 expression on peripheral bloodmononuclear cells (PBMCs).
Isolation of immune cells from brains. Brains harvested after PBS
perfusion were dispersed and digested with 1 mg/ml collagenase D
(Roche) and 0.1 mg/ml DNase I (Roche) at 37°C for 30 min. Dissociated
central nervous system (CNS) tissue was passed through a 70-m cell
strainer, followed by Percoll gradient (70%/37%) centrifugation. Mono-
nuclear cells were collected from the interphase, washed, and resuspended
in culture medium for further analysis.
Flow cytometry. The following anti-mouse monoclonal antibodies
were used: CD3 (145-2C11), CD4 (RM4-5), CD8 (53-6.7), gamma in-
terferon (IFN-	) (XMG1.2), tumor necrosis factor (TNF) (MP6-XT22),
interleukin 2 (IL-2) (JEH6-5H4), IL-10 (JES-2A5), IL-1
 (NJTEN3),
CD16/32 (2.4G2), CD45.1 (A20), CD45.2 (104), CD69 (H1.2F3), Ly6C
(AL-21), Ly6G (1A8), CXCR3 (CXCR3-173), CD11c (HL3), Siglec F
(E50-2440), I-A/E (M5/114.15.2), CCR2 (MC21), CD45 (30-F11), CD40
(HM40-3), CD86 (GL1), B220 (RA3-6B2), NK1.1(PK136), Foxp3 (FJK-
FIG 2 Robust virus-specific CD4 and CD8 T cell responses in the brains ofMavs/mice. Eight- to 12-week-oldWT andMavs/mice were infected with 100
PFUWNV s.c. CD8 (A and B) and CD4 (C and D) T cells from peripheral lymphoid organs (cervical [CLN] and popliteal [PLN] lymph nodes) and brains were
stained with NS4B tetramer (A and B) or stimulated with E641 peptide (C and D) at the indicated time points. The frequencies and numbers of tetramer CD8
T cells and IFN-	CD4 T cells are shown. (E and F) Brain cells were harvested at day 10 p.i. and stimulated with NS4B peptide (CD8 T cells) (E) or E641 peptide
(CD4 T cells) (F). The cells expressing IFN-	 and TNF, IL-10, or IL-2 are shown. n  3 mice/group/time point/experiment. *, P  0.05. The data are
representative of the results of 2 independent experiments. The error bars indicate SEM.
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16S), and BCL-2 (BCL/10C4) (all the antibodies were from BD Biosci-
ence, eBioscience, or Biolegend).
For surface staining, 106 cells were blocked with 1g anti-CD16/32 anti-
body and 1% rat serum and stained with the indicated antibodies at 4°C.
For in vitro intracellular cytokine/protein staining, 1  106 cells/well
were cultured in 96-well dishes at 37°C for 5 to 6 h in the presence of 2.5 to
10 M peptide (CD8, NS4B-2488 [SSVWNATTA]; CD4, E641 [PVGRL
VTVNPFVSVA]; BioSynthesis Inc., Lewisville, TX) or 20g/ml poly(I·C)
(Invivogen, San Diego, CA), brefeldin A (BFA) (BD Biosciences), and
antigen-presenting cells (CHB3 cells). The cells were then labeled for cell
surface markers, fixed/permeabilized with Cytofix/Cytoperm solution
(BDBiosciences), and labeledwith anti-intracellular cytokine/protein an-
tibodies.
To assess functional avidity, cells were stimulated with graded doses of
the relevant peptide pulsed onto CHB3 cells and examined for IFN-	
production. The frequency of CD8 T cells producing IFN-	 at each con-
centration of peptide was measured and expressed as a percentage of the
maximum response detected. The data were fitted to sigmoidal dose-
response curves and used to calculate the amount of peptide needed to
reach a half-maximum response (50% effective concentration [EC50]).
For major histocompatibility complex (MHC) class I tetramer stain-
ing, cells were stained with 8 g/ml allophycocyanin (APC)-conjugated
NS4B-2488 (SSVWNATTA) tetramers (obtained from theNational Insti-
tutes ofHealth,National Institute of Allergy and InfectiousDiseasesMHC
Tetramer Core Facility, Atlanta, GA) in complete RPMI 1640medium for
30 min at 4°C. For MHC class II tetramer staining, cells were stained with
E641 (PVGRLVTVNPFVSVA) tetramers for 60 min at 37°C. The cells
were then incubated with surface and intracellular markers. All flow cy-
tometry data were acquired on a BD FACSCalibur or BD FACSVerse and
analyzed using FlowJo software (Tree Star, Inc.).
In vivo cytotoxicity assay. In vivo cytotoxicity assays were performed
on day 7 after WNV infection, as previously described (10). Briefly,
splenocytes from CD45.1 congenic naive Mavs/ and WT mice were
stained with 2 M (Mavs/), 0.2 M (WT), or 0.004 M (1:1 WT-
Mavs/) carboxyfluorescein succinimidyl ester (CFSE) (Molecular
Probes, Eugene, OR) and then pulsed with the NS4B peptide (10 M) or
left unpulsed (0.004 MCFSE) at 37°C for 1 h. Cells (4 105) from each
group were mixed (1.2 106 cells in total) and transferred intravenously
(i.v.) into mice. At 4 h after transfer, total splenocytes were isolated.
Target cells were identified on the basis of CD45.1 staining and were
FIG 3 There are no differences in apoptosis or in proliferation in spleen-
derived T cells. Splenocytes fromnaiveWT andMavs/mice were harvested,
labeled with 2.5 M CFSE, and cultured in the presence of 1 g anti-CD3
MAb. After 66 h, cells were harvested and stained for caspase 8 (A), caspase 3/7
(B), BCL-2 (C), and CFSE dilution (D). (A and B) Left panels indicate WT
mice; right panels indicate Mavs/mice.
FIG 4 Virus-specific T cells are functional in vivo. WT and Mavs/ mice were infected with 100 PFU WNV s.c. (A and B) In vivo cytotoxicity assays were
performed on day 7 p.i. using CD8 T cell peptide (pep) NS4B-coated and control splenocytes as described in Materials and Methods. n  3 mice/group/
experiment. *, P  0.05; n.s., not significant. The data are representative of the results of 2 independent experiments. (C and D) Functional avidity of
NS4B-specific CD8 T cells in spleens and brains at day 10 p.i. (C) and the EC50 (D). *, P  0.05. The data are representative of the results of 4 independent
experiments. The error bars indicate SEM.
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distinguished from each other by differential CFSE staining. After gat-
ing on CD45.1 cells, the percent lysis was calculated as previously
described (10).
Generation of BMDCs and prime/boost immunization. Bone mar-
row-derived dendritic cells (BMDCs) were generated as previously de-
scribed (11). Briefly, cells were depleted of RBCs and plated at a density of
1 106/ml in X-vivo 15medium (LonzaWalkersville, Walkersville, MD)
supplemented with recombinant granulocyte-macrophage colony-stim-
ulating factor (1,000 U/ml; BD Pharmingen) and recombinant IL-4 (50
U/ml; eBioscience). After 6 days, the BMDCs were stimulated with 1
g/ml lipopolysaccharide (LPS) for 18 h and further incubated with or
without 1MNS4Bpeptide for 2 h at 37°C. CD11c dendritic cells (DCs)
were purified using CD11c microbeads and a Miltenyi autoMACS mag-
netic cell sorter (Miltenyi Biotec, Cologne, Germany). Purity was con-
firmed by flow cytometry. Mice were infected i.v. with BMDCs (5 105)
in 200 l PBS. Recombinant vaccinia virus expressing WNV NS4B
epitope (rVV-NS4B) was generated as previously described (12). Seven
days after BMDC/peptide immunization, themice were boosted with 1
106 PFU rVV-NS4B i.v. in 200 l PBS.
Microarray analysis. CD45 cells from the brains of four WT and
fourMavs/mice were separated as described above. RNA was purified
using a mirVana kit (Life Technologies) according to the manufacturer’s
instructions. RNA samples were assessed for purity and quality using an
Agilent 2100 Bioanalyzer. RNA for the microarray was processed using
a NuGenWT-Ovation Pico RNA amplification system, together with a
NuGen WT-Ovation Exon module. Samples were hybridized and
loaded onto Affymetrix Mouse gene 2.0. The arrays were scanned with a
HiScan bead array system, and data were collected using GeneChip oper-
ating software. Data from Affymetrix Mouse gene 2.0 Expression Bead-
Chip were normalized and median polished using Robust Multichip Av-
erage background correction with log2-adjusted values. After obtaining
the log2 expression values for genes, statistical analysis was performed
comparing the two groups (CD45 cells from brains ofWT andMavs/
mice). The significance of expression differences was assessed using a
false-discovery rate (FDR) cutoff of 0.05 and a 2-fold change. Analysis and
visualization of data and pathway analysis were performed using
PartekGS software and Ingenuity Pathway Analysis software.
Treg adoptive transfer. Lymphocytes were prepared from spleens and
lymph nodes of donor Mavs//Foxp3-IRES-GFP or Mavs//Foxp3-
IRES-GFP mice. CD4 T cells were negatively selected using a CD4 T
Cell isolation kit II (containing a biotinylated antibody cocktail) and
an AutoMACS (Miltenyi Biotech). Enriched CD4 T cells were labeled
with anti-mouse CD8-APC, B220-APC, and streptavidin-APC. Regula-
tory T cells (Tregs) (GFPhi) were then sorted twice using yield mode,
followed by purity mode, on a FACSDiva or FACSAria (BD). Cell purities
were typically 99.4% to 99.7%.Tregs (6105)were transferred adoptively
into Mavs/mice via the i.v. route.
Proliferation assay. Splenocytes (1106) fromWT orMavs/mice
were labeled with 2.5MCFSE (Invitrogen) and cultured in the presence
of 1 g of anti-CD3 monoclonal antibody (MAb) in a 96-well round-
bottom plate. After 66 h, cells were harvested and stained for CFSE dilu-
tion, caspases 3/7/8 (Invitrogen), and BCL-2 expression in CD4 and CD8
T cells.
Statistical analysis. A Student t test was used to analyze differences
in mean values between groups. The viral burden in tissues was ana-
lyzed by the Mann-Whitney test. Survival data were analyzed using a
Mantel-Cox log rank test. All results are expressed as means and stan-
dard errors of the mean (SEM). P values of 0.05 were considered
statistically significant.
Microarray data accession number. The complete microarray data
have been deposited at theGene ExpressionOmnibus under accession no.
GSE79417.
RESULTS
MAVS expression in CD45 hematopoietic cells is critical for
protection from WNV. In agreement with published results (3),
we found that Mavs/ mice uniformly succumbed to infection
with WNV, with death occurring by 14 days postinfection (p.i.).
Only 10 to 30% of WNV-infected WT mice died under the same
conditions (Fig. 1A). Large numbers of infiltrating CD45 cells
were detected inMavs/ brains between days 5 and 7 p.i., 2 days
earlier than observed in infected WT mice (Fig. 1B). To address
whether MAVS expression in these infiltrating cells or in nonhe-
FIG 5 Immunization with DC/peptide NS4B complexes did not induce protective CD8 T cell responses. WT, Mavs/, and Myd88/mice were immunized
with BMDCs pulsed with NS4B peptide. Seven days later, the mice were boosted with 1 106 PFU rVV-NS4B i.v. (A) Blood samples were harvested at day 5
postboosting and stained with NS4B tetramer. The frequencies of NS4B tetramerCD8 T cells are shown. (B and C)Mavs/ andMyd88/mice were infected
with 100 PFU WNV s.c. at 5 days or 5 weeks postboosting. (B) Survival in Mavs/ mice (no vaccination [No Vac], n  7; 5 days postboost, n  6; 5 weeks
postboost, n 8). (C) Survival in MyD88/mice (No Vac, n 15; 5 days postboost, n 6; 5 weeks postboost, n 10; P 0.0374 [5-day group compared to
No Vac group] and P 0.0067 [5-week group compared to No Vac group]). The error bars indicate SEM.
Zhao et al.
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matopoietic resident cells was most critical in preventing lethal
disease, we performed a set of reciprocal bone marrow transfers,
transferring Mavs/ or WT bone marrow to Mavs/ or WT
recipients, andmonitored themice for clinical disease, inflamma-
tory-cell infiltration, and virus clearance (Fig. 1C to E). Recipients
of Mavs/ cells developed more severe disease and uniformly
succumbed to the infection. The numbers of infiltrating cells were
significantly greater inmice that receivedMavs/ cells. However,
the kinetics of virus clearance was more nuanced. Clearance was
delayed in the brains and spleens if either donor or recipient mice
lackedMAVS expression. However, the results also demonstrated
that when the phenotype of the recipients (WT versus Mavs/)
WAS controlled for, mice that received Mavs/ donor cells
cleared virus more slowly than those that received WT cells.
These results demonstrate a key role for MAVS in mediating
severe disease in hematopoietic cells. Differences between trans-
ferred Mavs/ and WT bone marrow cells could reflect differ-
ences in the cellular composition of the naive spleen. However,
similar frequencies of dendritic cells, macrophages, neutrophils,
and lymphocytes were present in spleens from both WT and
Mavs/mice (data not shown).
Robust virus-specific CD4 and CD8 T cell responses in the
brains of Mavs/mice. Infiltrating hematopoietic cells include
lymphocytes and myeloid cells, and the number of virus-specific
T cells is increased in Mavs/ mice (3). Because these cells are
unable to clear WNV effectively, we assessed the quality of the T
cell response. A large fraction of T cells in the blood and peripheral
lymphoid tissue (spleen and cervical and popliteal lymph nodes)
were specific for singleWNV-specific epitopes, with nearly 50%of
blood CD8 T cells responding to a Db-restricted NS4B CD8 T cell
epitope (13) and 10% responding to an I-Ab-restricted E protein
CD4 T cell epitope (14), as measured by MHC class I/peptide
tetramer staining or peptide restimulation, respectively (Fig. 2A
and C). Similarly, the numbers of virus-specific CD8 and CD4 T
cells in the brains rapidly increased in Mavs/ mice, so that a
thousandfold more cells were detected at day 7 p.i. (Fig. 2B and
D). Virus-specific CD8 and CD4 T cells in Mavs/ and WT
brains were polyfunctional, with similar frequencies expressing
IFN-	 and TNF or IFN-	 and IL-2. Notably, a larger fraction of
cells from Mavs/ mice expressed both IFN-	 and IL-10, indi-
cating that the cells were highly activated (Fig. 2E and F) (15).
None of the cells expressed IL-4 or IL-17 (data not shown). This
FIG 6 Tregs do not protectMavs/mice from lethal infection. WT andMavs/mice were infected with 100 PFUWNV s.c. Cells from peripheral lymphoid
organs (A) or brains (B) were harvested at the indicated time points. The frequencies and numbers of Foxp3Tregs are shown. (C) Tregs (6 105) were purified
from Mavs//Foxp3-IRES-GFP or Mavs//Foxp3-IRES-GFP mice and adoptively transferred into Mavs/mice i.v. 1 day before WNV infection. Survival
wasmonitored daily (WTTreg, AT, n 5;Mavs/Treg, AT, n 5). AT, adoptive transfer. (D)WTmicewere infectedwithWNV.Cells frombrains and spleens
were harvested at day 10 p.i. The frequencies of E641 tetramer cells in Foxp3- CD4 T cells and Foxp3Tregs are shown. Cells from 4 to 6mice were pooled. The
data are representative of the results of 3 independent experiments. The error bars indicate SEM.
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large increase in T cell numbers, with equivalent production of
cytokines on a per cell basis, suggested that greatly increased levels
of proinflammatory cytokine were present in the infected
Mavs/ brain. To determine whether this increase in T cell num-
bers reflected intrinsic defects in apoptosis or T cell proliferation
in Mavs/mice, we treated splenocytes from naive mice in vitro
with anti-CD3 antibody. We detected no differences in T cell
apoptosis,measured by expression of activated caspases 3, 7, and 8
and BCL-2 (Fig. 3A and B), or proliferation, assessed by CFSE
dilution (Fig. 3C and D).
Virus-specific T cells are cytolytic in vivo but not protective.
While these results demonstrated high polyfunctionality, they did
not assess whether the virus-specific CD8 T cells were equally
cytolytic. To address this question, we performed an in vivo cyto-
toxicity assay, using NS4B peptide-pulsed splenocytes as target
cells. To control for differences in MAVS expression in both the
host and target cells, we transferredMavs/ andWT cells differ-
entially labeled with CFSE toMavs/ orWTmice intravenously.
As shown in Fig. 4A and B, both targets were killed equivalently in
the spleen by 4 h after transfer. Consistent with the greater fre-
quency and numbers of virus-specific CD8 T cells, a higher per-
centage of target cells were lysed in Mavs/mice.
Anothermeasure of T cell functionality is the ability to respond
to small amounts of peptide (functional avidity). NS4B-specific
CD8 T cells from the brains of Mavs/ mice exhibited approxi-
mately 5-fold-lower functional avidity than brain cells harvested
from WT mice (Fig. 4C and D). There were only modest differ-
ences in functional avidity when spleen-derived cells were com-
pared, demonstrating that high-functional-avidity cells prefer-
entially migrated to the brains of WT-infected mice, but not
Mavs/-infected mice. This decreased functional avidity makes
it likely that the cells were less able to efficiently clear virus from
infected Mavs/ brains.
To address whether memory virus-specific CD8 T cells could
protect Mavs/ mice, we performed a prime-boost vaccination
strategy, immunizing mice with DCs coated with NS4B peptide,
followed by boosting at day 7 with vaccinia virus expressing the
same epitope. This regimen effectively and rapidly induces mem-
ory T cells (16). We infected Myd88/ mice as a control, since
thesemice are deficient in type I IFN induction and also are highly
susceptible to WNV (6). This prime-boost strategy induced sim-
ilar frequencies of NS4B-specific cells in the blood of all three
groups (Fig. 5A). However, challenge ofMavs/micewithWNV
at either 5 days or 5 weeks postboost was not protective (Fig. 5B).
In contrast, Myd88/ mice were either completely (5 days after
boosting) or partially (5 weeks after boosting) protected (Fig. 5C).
Thus, even preexisting high levels of memory virus-specific CD8
T cells were unable to protectMavs/mice. Of note, CD8 T cells
are required for protection, becausemost of the unvaccinatedWT
FIG 7 Increase in macrophage numbers inMavs/ compared toWT brains. Cells fromWNV-infected (day 10 p.i.) (A) or naive (B) brains were harvested and
stained for macrophages (CD45 CD11b Ly6C Ly6G), microglia (CD45 CD11b Ly6C Ly6G), and neutrophils (CD45 CD11b Ly6C Ly6G).
Frequencies and numbers are shown. (C) Bone marrow chimeric mice were infected with 100 PFUWNV s.c. Cells from the brains were harvested at day 10 p.i.
and stained for macrophages, microglia, and neutrophils. n  7 to 9 mice/group/time point. *, P  0.05. The data were pooled from the results of three
independent experiments. The error bars indicate SEM.
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mice died if these cells were depleted prior to infection, consistent
with published data (reference 17 and data not shown).
Regulatory T cells do not protect Mavs/mice from lethal
infection. Previous studies demonstrated a lower frequency of
Foxp3 Tregs in the blood of patients with symptomatic (versus
asymptomatic) WNV infection and in mice with more severe dis-
ease (18). WNV clinical disease was also more severe in Treg-
depleted mice, suggesting a role in ameliorating an excessive in-
flammatory response (18). The frequencies of Tregs in peripheral
lymphoid tissue were similar at all times p.i. in Mavs/ and WT
mice; Treg frequency in the blood, however, was greatly decreased
in Mavs/ mice (Fig. 6A). More strikingly, Treg numbers re-
mained largely unchanged in the brain after infection ofMavs/
mice, resulting in a sharp decrease in frequency, reflecting the
increase in total numbers of infiltrating cells. In contrast, Treg
frequency decreased only modestly inWTmice while the number
of cells increased as the infection progressed (Fig. 6B). Since these
results were consistent with an ameliorating effect of Tregs, we
transferred 6  105 WT or Mavs/ Tregs to infected Mavs/
mice. We transferred 6 105 Tregs because that number amelio-
rated disease in mice infected with another neurotropic virus
(mouse hepatitis virus, a murine coronavirus) (19) However, in
neither case was lethality prevented (Fig. 6C). Of note, approxi-
mately 3.5% or 1.5% of Tregs were specific for an epitope in the
infected brains or spleens, respectively, of WT mice at day 10 p.i.
(Fig. 6D).
Large increase in macrophage numbers in Mavs/ com-
pared to WT brains. The frequency of brain-infiltrating macro-
phages increased 10-fold and their number increased 100- to
1,000-fold by day 7 p.i. inMavs/ compared toWTmice; similar
changes in the frequency and number of neutrophils were also
observed (Fig. 7A).No differences in the frequencies and numbers
of microglia/macrophages/neutrophils were detected in the unin-
fectedMavs/ brain (Fig. 7B). To determinewhether augmented
macrophage and neutrophil infiltration was dependent upon
MAVS expression in hematopoietic cells, we developed bonemar-
row chimeras, shown in Fig. 1. Recipients of Mavs/ bone mar-
row demonstrated higher frequencies of macrophages, indepen-
dent of whether the host expressed MAVS (Fig. 7C). Numbers of
macrophages, as well as neutrophils, were also increased in the
brains of these mice, since recipients of Mavs/ cells showed
significantly higher total numbers of infiltrating cells in the brain
(Fig. 1D).
Macrophages and microglia from Mavs/ brains expressed
significantly higher levels of MHC class II antigen, required for
antigen presentation and likely critical for propagating the inflam-
matory process in the brains. In addition, we detected modest but
statistically significant increases in activation markers on macro-
phages (CXCR3) and microglia (CD40, CD69, and CD86) (Fig.
8A). To examine the functional consequences of activation, we
assessed cytokine production by brain-derived macrophages and
microglia. Similar frequencies of macrophages and microglia iso-
lated from bothMavs/ andWTmice expressed TNF and IL-1

in the absence of further stimulation, showing that these cells were
activated equivalently in vivo (only Mavs/ mice are shown in
Fig. 8B). Direct ex vivo stimulation with poly(I·C) equivalently
increased the frequency of cells that expressed TNF and IL-1
 in
both naive and infected brains. However, there were substantially
more macrophages expressing these cytokines in WNV-infected
Mavs/ mice, since the total numbers of macrophages were
FIG 8 Enhanced activation of macrophages and microglia in Mavs/ compared to WT brains. WT and Mavs/mice were infected with 100 PFU WNV s.c.
(A) Cells from brains were harvested at day 10 p.i. and stained with phenotypic markers. Geometric mean fluorescence intensities (MFI) are shown. *, P 0.05.
The data are representative of the results of 2 independent experiments. n  3 mice/group/time point/experiment. (B) Macrophages and microglia were
stimulatedwith 20g/ml poly(I·C) in the presence of BFA in vitro for 6 h and stained for intracellular TNF and IL-1
 expression. (C andD)Cytokine-expressing-
cell numbers in infected (C) and naive (D)mice. n 9mice/group/time point. *, P 0.05. The data were pooled from three independent experiments. The error
bars indicate SEM.
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greater (Fig. 8C).No differences in inflammatory cytokine expres-
sion were found in macrophages and microglia in uninfected
brains of either Mavs/ or WT mice (Fig. 8D). Our results thus
far showed that there was more infiltration of activated myeloid
and T cells in Mavs/ than in WT brains.
Increased inflammation in WNV-infected Mavs/ brains
assessed by microarray analysis. To assess enhanced inflamma-
tionmore globally, we performedmicroarray analyses using RNA
extracted from brain-derived CD45 cells harvested from 4 WT
and 4Mavs/mice at day 10 p.i. We found that 1,104 genes were
differentially regulated when Mavs/ and WT mice were com-
pared, with 620 genes increased in expression in Mavs/ mice
compared to WT mice and a smaller number (484) reduced in
expression compared to WT mice (Fig. 9A). Of note, most of the
FIG 9 Differential gene expression in CD45 cells in brains fromWT andMavs/mice. RNA was prepared from CD45 cells harvested from the brains of 4
Mavs/ and 4 WT mice at day 10 p.i. and analyzed as described in Materials and Methods. (A) Numbers of genes upregulated or downregulated in Mavs/
compared to WT mice. A total of 1,104 genes were differentially regulated. (B) Expression of genes [log(P value)] in the disease and function pathways. (C)
Differentially expressed genes in the inflammatory response pathway (boxed in panel B). (D) Heat map of selected genes involved in the inflammation of organs
pathway.
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downregulated genes encode proteins that have not been anno-
tated. Using Ingenuity Pathway Analysis (IPA) to identify gene
pathways, we found that 281 genes in the Disease and Function
pathwaywere differentially regulated, withmost of them classified
in the cellular immune response (Fig. 9B; see Table S1 in the sup-
plemental material). The vast majority of these genes were in-
creased in expression inMavs/mice. In particular, significantly
more genes associated with the inflammatory response were ex-
pressed at high levels in Mavs/ than in WT mice (Fig. 9C and
D), consistent with the overwhelming amount of inflammation
detected in these mice.
DISCUSSION
The host immune response functions inWNV-infected animals to
limit virus replication in the periphery and to diminish invasion
and infection of the central nervous system (2). Here, we show
that MAVS, expressed primarily by hematopoietic cells, is critical
for both processes. Based on results in this and previous reports
(3), MAVS-dependent expression of type I interferon and other
inflammatory molecules by macrophages is necessary to orches-
trate a balanced innate immune response and a subsequent pro-
tective T cell response. In the absence of MAVS expression, type I
IFN and other proinflammatory mediators are probably pro-
duced by other cells via MAVS-independent pathways, such as
through Toll-like receptor (TLR), MyD88, and STING signaling
(6, 20–22), resulting in high levels in the blood. Furthermore,
prolonged and elevated virus titers elicit a protracted innate im-
mune response in both the periphery and brain (3). TNF, one of
the circulating cytokines, has been shown to contribute to break-
down of the blood-brain barrier (BBB) and enhanced entry of
WNV and inflammatory cells into the brain (20); other cytokines,
such as IL-6, IFN-	, CXCL10, and type I interferon, are also in-
creased in sera from Mavs/ mice and may contribute to these
processes (3). Some cytokines, such as TNF and IL-1
, are known
to be toxic to neurons, which could cause neuronal injury and
contribute to WNV encephalitis (23, 24). Together, these data
indicate that the relative temporal and spatial expression of viral
gene products and inflammatory mediators differs from that ob-
served in WT mice, resulting in a dysregulated immune response
in WNV-infected Mavs/ mice and poor outcomes. Immune
dysregulation was not confined to cytokine production, since
global gene expression analyses of infected Mavs/ brains
showed extensive upregulation of genes associated with inflam-
mation in general compared to WT mice.
A downstream consequence of increased virus load and over-
exuberant proinflammatory cytokines is massive infiltration of
virus-specific T cells and CD11b Ly6C myeloid cells into the
brain and microglion activation. Elevated numbers of macro-
phages have been observed in mice infected with WNV and other
neurotropic viruses, and this was observed to contribute to worse
outcomes (25–28). Macrophages and microglia in the WNV-in-
fected brain expressed high levels of MHC class II, which contrib-
utes to in situ activation and proliferation of virus-specific and
perhaps bystander T cells. Virus-specific T cell numbers were
greatly increased in the spleen and brain, and the cells were func-
tional, as assessed using an in vivo cytotoxicity assay. The relative
increase was greater in the brains ofMavs/mice than in those of
WT mice, likely reflecting differences in the viral antigen burden
and levels of cytokines, such as IL-2, which enhance proliferation.
There were no intrinsic differences in the ability to proliferate
between MAVS/ and WT T cells because proliferation was ap-
proximately the same after CD3 stimulation in vitro (Fig. 3). Most
importantly, NS4B-specific cells with high functional avidity mi-
grated to or proliferated in the brains of WT-infected mice,
whereas there was no selection for such highly functional cells in
Mavs/mice. This accumulation of low-avidity antigen-specific
T cells in the brain may have contributed to poor virus clearance.
Another possible factor contributory to worse outcomes in
Mavs/ mice is a lack of expansion of regulatory T cells. Tregs
modulate the inflammatory response to minimize host damage
but also may inhibit effective virus clearance (29). Treg numbers
were increased in WNV-infected patients with milder disease
(18), and the numbers of Tregs in the brain correlated with better
clinical outcomes in mice infected with other neurotropic virus
infections (30). Tregs were detected in both Mavs/ and WT
brains at day 5 p.i., but their numbers failed to increase in
MAVS/mice while they increased inWTmice as infection pro-
gressed. Since the total numbers of CD4 T cells continued to in-
crease in the brains of Mavs/ mice, the Treg frequency de-
creased substantially. Whether this lack of Treg increase in brains
of Mavs/ mice reflects a specific requirement for a MAVS-de-
pendent gene in myeloid cells or direct inhibition of Treg prolif-
eration by the inflammatory milieu present in these mice requires
additional investigation. It is also possible that Tregs may not
function optimally in the highly inflamed CNS of WNV-infected
Mavs/ mice. Consistent with this idea, myelin-specific Tregs
were suboptimally suppressive in the inflammatory environment
present in mice with experimental autoimmune encephalomyeli-
tis (EAE) (31). In thesemice, the loss of suppressive capability was
mediated by TNF and IL-6.
Collectively, our results demonstrate a complex and multifacto-
rial basis for severe disease in WNV-infected Mavs/ mice, with
MAVS expression in hematopoietic cells being critical for orchestrat-
ing a protective immune response.Our experiments also suggest that
targeting of myeloid cell subsets may be a useful intervention in en-
hancing the anti-WNV protective immune response.
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